Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress.
We examined increased sensitivity to stress in relation to spontaneous recurrences of methamphetamine (MAP) psychosis (i.e., flashbacks). Plasma monoamine metabolite levels were assayed in: 26 flashbackers, of whom 11 were on neuroleptics before and during the study, and the other 15 received neuroleptics in the course of the study; 18 non-flashbackers with a history of MAP psychosis; eight subjects with persistent MAP psychosis; and 23 MAP user and 11 non-user controls. The 26 flashbackers had experienced stressful events and/or MAP-induced fear-related psychotic symptoms during previous MAP use. Mild psychosocial stressors then triggered flashbacks. During flashbacks plasma norepinephrine levels increased markedly; among the flashbackers, those with a history of stressful events, whether or not they had experienced fear-related symptoms, showed a further increase in 3-methoxytyramine levels. Stressful experiences, together with MAP use, may therefore induce sensitization to stress associated with noradrenergic hyperactivity, involving increased dopamine release, and so triggering flashbacks.
Yui
K
K
Department of Psychiatry, Jichi Medical School, Minamikawachi, Tochigi, Japan. kyui@jichi.ac.jp
Goto
K
K
Ikemoto
S
S
Ishiguro
T
T
D000328:Adult; D000704:Analysis of Variance; D015306:Biogenic Monoamines / Q000097:blood; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D016009:Chi-Square Distribution; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D008694:Methamphetamine / Q000009:adverse effects*; D011329:Prisoners; D011605:Psychoses, Substance-Induced / Q000097:blood / Q000209:etiology / Q000503:physiopathology*; D012008:Recurrence; D018709:Statistics, Nonparametric; D013315:Stress, Psychological / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D019966:Substance-Related Disorders / Q000150:complications
D015306:Biogenic Monoamines; D000697:Central Nervous System Stimulants; D008694:Methamphetamine